Skip to contentC
Cardio Diagnostics Holdings, Inc.
C
CDIOCardio Diagnostics Holdings, Inc. Q1 2026 · 10-Q
Revenue$2.68K$2.68K+185.1% vs Q1 2025 Net Income-$1.79M-$1.79MN/M vs Q1 2025 EPS Diluted-$0.63-$0.63N/M vs Q1 2025 Operating Income-$1,784,837N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardio Diagnostics Holdings, Inc. · CIK 1870144 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,563,972N/M Margins · derivedOperating margin-66598.4%+106865.4 pt vs Q1 2025
Net margin-66722.3%+107220.7 pt vs Q1 2025
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end